Identification of a Genetic Signature Enriching for Response to Ibrutinib in Relapsed/Refractory Follicular Lymphoma in the Dawn Phase 2 Trial

Autor: Balasubramanian, Sriram, Hodkinson, Brendan *, Schuster, Stephen J., Fowler, Nathan H., Trotman, Judith *, Hess, Georg *, Cheson, Bruce, Schaffer, Michael *, Wang, Shean-Sheng *, Deshpande, Sanjay *, Vermeulen, Jessica *, Salles, Gilles, Gopal, Ajay K.
Zdroj: In Blood 29 November 2018 132 Supplement 1:4147-4147
Databáze: ScienceDirect